New data suggests Veracyte’s RNA-Seq based Afirma GSC can help patients avoid unnecessary thyroid surgery

March 20, 2018 Leave a comment 3,012 Views

Veracyte, Inc. today announced that new data presented at ENDO 2018, the annual meeting of the Endocrine Society, suggest that the Afirma Genomic Sequencing Classifier (GSC) can help significantly more

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Endocrine Society

New data suggests Veracyte’s RNA-Seq based Afirma GSC can help patients avoid unnecessary thyroid surgery

Versatile, facile and low-cost single-cell isolation, culture and sequencing by optical tweezer-assisted pool-screening

PacBio and Boston Children’s Hospital collaborate to investigate novel variants inaccessible by short-read sequencing

RNA-Seq links severe COVID-19 with molecular signatures of brain aging

Call for Papers – Applications of RNA-Seq in Cancer and Tumor Research

Exai Bio’s RNA sequencing-based liquid biopsy platform delivers promising data on detecting breast cancer at its earliest stages

Transcriptomic technique may help identify infections after knee and hip replacement

AS-CMC – a pan-cancer database of alternative splicing for molecular classification of cancer